Home0775 • HKG
Follow
CK Life Sciences Intl (Holdings) Inc
Previous close
$0.34
Day range
$0.34 - $0.35
Year range
$0.30 - $0.82
Market cap
3.27B HKD
Avg Volume
8.05M
P/E ratio
189.94
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (HKD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 1.37B | 0.31% |
Operating expense | 368.88M | 0.23% |
Net income | -9.83M | -129.42% |
Net profit margin | -0.72 | -129.51% |
Earnings per share | — | — |
EBITDA | 88.46M | -3.34% |
Effective tax rate | 267.56% | — |
Balance Sheet
Total assets
Total liabilities
| (HKD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 676.16M | -3.97% |
Total assets | 11.25B | -0.17% |
Total liabilities | 7.06B | -0.75% |
Total equity | 4.19B | — |
Shares outstanding | 9.61B | — |
Price to book | 0.77 | — |
Return on assets | 1.11% | — |
Return on capital | 1.23% | — |
Cash Flow
Net change in cash
| (HKD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -9.83M | -129.42% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector. Wikipedia
CEO
Founded
2000
Website
Employees
1,932
